相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase
Stefano Alcaro et al.
DRUG RESISTANCE UPDATES (2011)
Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
Johan Vingerhoets et al.
AIDS (2010)
Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1
Romuald Corbau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Distinct Mutation Pathways of Non-Subtype B HIV-1 during In Vitro Resistance Selection with Nonnucleoside Reverse Transcriptase Inhibitors
Ming-Tain Lai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)
Marie-Pierre de Bethune
ANTIVIRAL RESEARCH (2010)
Molecular basis of human immunodeficiency virus drug resistance: An update
Luis Menendez-Arias
ANTIVIRAL RESEARCH (2010)
Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design
Eric B. Lansdon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance
Jing Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations
J. Wang et al.
VIROLOGY (2010)
The search for potent, small molecule NNRTIs: A review
Dhaval G. Prajapati et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Another Ten Stories in Antiviral Drug Discovery (Part C): Old and New Antivirals, Strategies, and Perspectives
Erik De Clercq
MEDICINAL RESEARCH REVIEWS (2009)
A study of the binding energies of efavirenz to wild-type and K103N/Y181C HIV-1 reverse transcriptase based on the ONIOM method
Pensri Srivab et al.
CHEMMEDCHEM (2008)
Specific enfuvirtide-associated mutational pathways in HIV-1 gp41 are significantly correlated with an increase in CD4+ cell count, despite virological failure
Valentina Svicher et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
Kalyan Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase
Jingshan Ren et al.
VIRUS RESEARCH (2008)
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine
Stefania Paolucci et al.
ANTIVIRAL RESEARCH (2007)
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors
Francesca Ceccherini-Silberstein et al.
JOURNAL OF VIROLOGY (2007)
Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases
Jingshan Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097
Kalyan Das et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138
Jingshan Ren et al.
FEBS JOURNAL (2006)
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
Valentina Svicher et al.
JOURNAL OF VIROLOGY (2006)
Computational methods for the design of effective therapies against drug resistant HIV strains
N Beerenwinkel et al.
BIOINFORMATICS (2005)
TMC125 displays a high genetic barrier to the development of resistance:: Evidence from in vitro selection experiments
J Vingerhoets et al.
JOURNAL OF VIROLOGY (2005)
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
PR Harrigan et al.
AIDS (2005)
Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site as explained by the ONIOM2 method
P Nunrium et al.
CHEMICAL PHYSICS LETTERS (2005)
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1
J Guillemont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Medical progress: HIV drug resistance
F Clavel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Understanding the basis of resistance in the irksome Lys103Asn HIV-1 reverse transcriptase mutant through targeted molecular dynamics simulations
F Rodríguez-Barrios et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1
K Andries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Antiviral drugs in current clinical use
E De Clercq
JOURNAL OF CLINICAL VIROLOGY (2004)
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding
N Sluis-Cremer et al.
CURRENT HIV RESEARCH (2004)
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
K Das et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1
J Balzarini
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Geno2pheno:: estimating phenotypic drug resistance from HIV-1 genotypes
N Beerenwinkel et al.
NUCLEIC ACIDS RESEARCH (2003)
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee et al.
NUCLEIC ACIDS RESEARCH (2003)
Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant
J Lindberg et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors
J Ren et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
The Lys103Asn mutation of HIV-1 RT:: A novel mechanism of drug resistance
Y Hsiou et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase
J Ren et al.
STRUCTURE (2000)
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy
LT Bacheler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
